US Rare Cancer Market FDA Approved Rare Cancer Drug Clinical Trials Insight
Kuick Research Report Gives Detailed Insight On Ongoing Rare Disease Drug Market And Highlights Ongoing Clinical Trials
Delhi, May 15, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030
Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs
Clinical Trials Insight By Company, Indication, Phase and Priority Status
Insight On FDA Designated Marketed Orphan Drugs: > 500 Orphan Drugs
Pricing and Dosage Insight: > 400 Marketed Orphan Drugs
US, Global, Regional, Annual Sales Insight (2019 – Q1'2025): >150 Orphan Drugs
Sales, Price and Dosage Data Represented In More Than 1000 Charts and Tables
Orphan Designation Insight By Indication, Company, Trial Phase, Marketed Drugs Represented In 1000 Tables
Download US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report:
https://www.kuickresearch.com/report-fda-orphan-drug-database
The US orphan market for rare cancers is a specialized oncology frontier that has seen tremendous development over the last decade. Each of these rare cancers, which individually affect fewer than 200,000 Americans, collectively affect millions of patients and their families and pose unique therapeutic challenges. Traditionally underserved with scant commercial interest, rare cancer therapies are now a center of innovation, with around 50% of all orphan drug designations aimed at oncology conditions. This niche market has expanded to a very lucrative segment, with scientific progress fueling clinical progress and commercial opportunity alike.
Rare cancer therapies illustrate the potential for focused strategies to transform patient care. Bristol Myers Squibb's Opdivo (nivolumab), originally approved for rare types of Hodgkin lymphoma, is the successful development track many orphan oncology drugs take. Initially approved for restricted indications in small patient populations, Opdivo eventually gained approval for more extensive uses, revolutionizing treatment paradigms in several types of cancer. This strategy for development, targeted at defined patient populations, has become increasingly common, enabling firms to validate clinical proof-of-concept before expanding use.
Precision medicine revolutionized the rare cancer space by making it possible to segment ordinary cancers into rare subtypes through molecular segmentation. Bayer's Vitrakvi (larotrectinib) is a prime example of this strategy, treating rare TRK fusion-positive cancers in several types of tumors instead of targeting common anatomical classes. This tissue-agnostic approval process has reframed the way that rare cancers are imagined, opening up possibilities for therapies focused on particular genetic mutations that occur in small groups of patients across many types of cancer. So, too, does Roche's Rozlytrek (entrectinib) target ROS1-positive non-small cell lung cancer, a rare molecular subgroup that occurs in about 2% of lung cancer patients.
Outside of conventional pharma, the rare cancer segment has welcomed next-generation therapeutic modalities. Kymriah (tisagenlecleucel), Novartis's CAR-T cell therapy for rare B-cell cancers, illustrates how cellular therapies have gained early use in rare cancer indications where unmet need warrants novel approaches. This pattern carries over to antibody-drug conjugates such as Pfizer's Adcetris (brentuximab vedotin) for Hodgkin lymphoma and systemic anaplastic large cell lymphoma, marrying targeted delivery mechanisms with highly active cytotoxic agents to achieve maximum efficacy while limiting systemic toxicity.
The orphan cancer drug environment for rare malignancies has enabled specialist development firms dedicated entirely to underrepresented cancers. Epizyme (acquired by Ipsen) developed its clinical pipeline from rare epigenetic cancer targets and gained approval for Tazverik (tazemetostat) in epithelioid sarcoma and follicular lymphoma. In the same vein, Y-mAbs Therapeutics has also focused on rare pediatric malignancies, with the development of Danyelza (naxitamab) for neuroblastoma, which occurs in about 700 children per year in the US.
Collaborative models have gained prominence in rare cancer drug development. The Rare Cancer Research Foundation has organized tissue donation programs and research networks that link patients with scientists who are working on developing targeted therapies. Likewise, the TARGET pediatric cancer program has expedited molecular characterization of rare childhood cancers, generating publicly available datasets that guide drug development across the industry. These collaborative strategies overcome the inherent difficulties of creating treatments for diseases where patient populations are geographically remote and clinical trial recruitment is challenging.
In the future, the rare cancer orphan drug market in the US is expected to evolve to develop with new technologies, such as artificial intelligence driving drug discovery and development. Machine learning computations are assisting the identification of new targets in uncommon cancers by studying intricate molecular datasets, and electronic platforms bring highly scattered patients in touch with the right clinical trials. These technological advances, together with growing biological insights into the drivers of rare cancers, predict the orphan oncology space as a vibrant domain for scientific breakthrough and therapeutic progress, bringing patients new hope that has long eluded them.
CONTACT: Neeraj Chawla Research Head Kuick Research neeraj@kuickresearch.com https://www.kuickresearch.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
an hour ago
What's in and out of Trump's big bill as Senate races to meet Fourth of July deadline
WASHINGTON -- President Donald Trump says 'NO ONE GOES ON VACATION' until the big, beautiful bill is on his desk by the Fourth of July deadline. And Republicans in Congress are staying put to get it done. The Senate is gearing up for weekend work, while House Speaker Mike Johnson told lawmakers Tuesday to keep their schedules 'flexible' as they prepare for more votes. 'We are making good headway,' said Senate Majority Leader John Thune, R-S.D. He expects the Senate will get this "past the finish line' by the end of the week, sending it back to the House for swift action. But Republicans who have majority control of the House and Senate are finding that their push to move fast and change things — namely cuts to federal government programs including Medicaid and SNAP food stamps used by millions of Americans — is easier said than done. Not all GOP lawmakers are on board, and the Senate parliamentarian has advised that several key proposals violate procedural rules. With Democrats flatly opposed, it's all leaving GOP leaders scrambling days before final votes. Here's the latest on what's in, out and still up for debate as lawmakers work to finish the massive 1,000-page plus package. The top priority for Republicans is preventing what they warn would be a massive tax hike, some $3.8 trillion, after December when the tax breaks they put in place during Trump's first term, in 2017, expire. The big bill seeks to make existing tax rates and brackets permanent, while also temporarily adding new ones Trump campaigned on — no taxes on tips, overtime pay or some automotive loans, along with a bigger $6,000 deduction in the Senate draft for seniors who earn no more than $75,000 a year. The wealthiest households would see a $12,000 increase, while the bill would cost the poorest people $1,600 a year, according to the nonpartisan Congressional Budget Office. Middle income taxpayers would see a tax break of $500 to $1,500, CBO said. One provision for families would boost the $2,000 child tax credit to $2,200 under the Senate proposal or $2,500 in the House. But families at lower income levels won't see the full amount, if any. And one unresolved issue is the House's proposed $40,000 cap on state and local deductions, called SALT, that GOP senators say is too high and want limited. There's also some $350 billion of new funding in the package for Trump's border and national security agenda. Trump promises the largest mass deportation operation in U.S. history, and the package proposes money to hire 10,000 new Immigration and Customs Enforcement officers, with $10,000 signing bonuses, and for 100,000 immigration detention beds with a goal of deporting some 1 million people a year. Additionally, the House bill proposes $12 billion for the Homeland Security secretary to provide grants to states that help with federal immigration enforcement and deportation actions. The Senate package also provides the attorney general with $3.5 billion to create a similar state fund — called Bridging Immigration-related Deficits Experienced Nationwide, or Biden, referring to the former president. Immigrants entering the U.S. would face stiff new fees, including $1,000 for those seeking asylum protections. There's also money for the development of Trump's 'Golden Dome' missile defense system over the U.S., and quality of life measures for servicemen and women. And there are extras: One provision from the Senate would provide $40 million to establish Trump's long-sought 'National Garden of American Heroes.' To help partly offset the lost tax revenue, Republicans are seeking to cut back some long-running government programs — Medicaid, food stamps and green energy incentives — basically unraveling the accomplishments of the past two Democratic presidents: Joe Biden and Barack Obama. Republicans argue they are trying to right-size the safety net programs for the population they were initially designed to serve — mainly pregnant women and children — and root out waste, fraud and abuse. The package includes new 80-hour-a-month work requirements for many adults receiving Medicaid and food stamps, including older people up to age 65. Parents of children older than 10 would have to work to qualify for food aid, and those with teens would have to comply with the work requirement for Medicaid. 'It's wildly popular,' Johnson said Tuesday, noting people can work, volunteer or go to school or job training programs. "For heaven's sake, do something constructive." Some 80 million Americans rely on Medicaid, which expanded under Obama's Affordable Care Act, and 40 million use the Supplemental Nutritional Assistance Program, and most already work, according to analysts. All told, the CBO estimates at least 10.9 million more people would go without health coverage, and 3 million more would not qualify for food stamps. Deeper SNAP cuts that would shift cost-sharing to the states were called into question by the Senate parliamentarian and undergoing revisions. And more Medicaid changes are up for debate — including a Senate plan to reduce the so-called provider tax that most states impose on hospitals and other entities. Key GOP senators and a coalition of House Republicans warn that lower Medicaid provider tax cuts will hurt rural hospitals. 'We cannot support a final bill that threatens access to coverage,' said 16 House GOP lawmakers in a letter to leadership. Senators are considering the creation of a new rural hospital fund, but the plan remains a work in progress. They've also had objections to the House's proposed new $35 co-pay on Medicaid services. Both the House and Senate bills propose a dramatic rollback of the Biden-era green energy tax breaks for electric vehicles and also the production and investment tax credits companies use to stand up wind, solar and other renewable energy projects. All told, the cuts to Medicaid, food stamps and green energy programs are expected to produce at least $1.5 trillion in savings. Altogether, keeping the existing tax breaks and adding the new ones is expected to cost $3.8 trillion over the decade, CBO says in its analysis of the House bill. The Senate draft is slightly higher. The spending cuts tally at least $1.5 trillion. The CBO estimates the package from the House would add $2.4 trillion to the nation's deficits over the decade. Or not, depending on how one does the math. Senate Republicans are proposing a unique strategy of not counting the existing tax breaks as a new cost, because they're already 'current policy.' They argue the Budget Committee chairman has the authority to set the baseline for its preferred approach. Under the Senate GOP view, the cost of tax provisions would be $441 billion, according to the congressional Joint Committee on Taxation. Democrats and others argue this is 'magic math' that obscures the costs of the GOP tax breaks. The Committee for a Responsible Federal Budget puts the Senate tally at $4.2 trillion over the decade. 'Current policy baseline' is a budget gimmick,' said Sen. Jeff Merkley, the top Democrat on the Budget Committee. 'This bill will add trillions upon trillions of dollars to the national debt to fund tax breaks for billionaires.' Trump, en route to Europe for a NATO meeting, told senators to lock themselves in a room if needed, and 'GET THE BILL DONE.'
Yahoo
2 hours ago
- Yahoo
AP Top Extended Financial Headlines at 2:00 a.m. EDT
Americans' view of the economy worsened in June, wiping out much of the previous month's gain which followed a string of declines that had dragged consumer confidence to its lowest level since the COVID-19 pandemic five years ago
Yahoo
2 hours ago
- Yahoo
Gen X is the least financially secure generation — and most Americans say they need six figures to live comfortably
More than a quarter of Americans say they would need to be making at least $150,000 to feel financially secure, and more than three-quarters of Americans say they currently don't feel financially secure — especially those who belong to Generation X. More than three-quarters of U.S. adults say they aren't completely financially secure, which is up from 72 percent in 2023 and 75 percent in 2024, according to Bankrate's Financial Freedom Survey. While just over a quarter of Americans told Bankrate they would feel secure if they could make $150,000, a large percentage of respondents — 45 percent — said they need to make at least six figures before they could begin to feel secure. Feeling financially secure, as defined by Bankrate's survey, is the ability to 'cover your bills and everyday essentials but also have money left over for eating out and vacations.' That growing sense of financial instability is fueled by several factors. 'One major issue is that wages have been stagnant for a large majority of the population over that time, and prices continue to rise,' Carolyn McClanahan, a certified financial planner and founder of Life Planning Partners in Jacksonville, Florida, told Bankrate. 'Add that to the backdrop of political instability everyone is feeling, and I think that is a perfect formula for people not feeling financially secure,' she said, The cost of goods are not the only major expense on the rise. There's also child care, auto loans, home insurance, outstanding student loan balances, and of course, rent. While all U.S. adults are subject to these forces, Generation X may be one of the hardest hit. Gen Xers — people who are currently between the ages of 45 and 60 — have now been working for decades. But the oldest of that cohort is still at least seven years away from the retirement age. Bankrate's survey found that 84 percent of Gen Xers felt they weren't being paid enough to feel financially secure. The survey found that 80 percent of Generation Z respondents felt the same way, as did 79 percent of Millennials and 69 percent of Baby Boomers. According to a 2024 Experian survey, Gen X has experienced the most 'financial trauma' — defined by Trauma of Money author Chanel Chapman as emotional distress directly linked to monetary concerns and its impact on their relationships, families, and perspectives on wealth. In that survey, 74 percent of Gen X respondents said they were experiencing financial trauma, followed by 71 percent of Millennials, 64 percent of Gen Z, and 63 percent of Baby Boomers. Gen Xers are in the unenviable position of nearing the end of their careers while also having to care for children and aging loved ones and navigating the challenging modern financial landscape. Gen X was also in the prime earning years during the Great Recession, and were the first generation born after the broad elimination of pensions in the United States. In the Bankrate survey, 35 percent of Gen Xers said they would need to rake in at least$150,000 annually to feel financially comfortable, while 24 percent of Baby Boomers, 26 percent of Millennials, and 20 percent of Gen Zers said the same. While Gen X may be struggling the most, all the surveys show that more than half of all U.S. adults are feeling the pressure to make ends meet. According to Bankrate, rapid inflation over the last three years has undermined households' purchasing power, which makes it harder for Americans to afford their lifestyles on their current salaries. A salary of $100,000 in January 2020 has the same buying power as $124,353, according to Bankrate. That means that if the worker making $100,000 hasn't received a raise between 2020 and 2025, they've effectively lost $24,000 of their salary. But for the nearly 900,000 Americans who make minimum wage, reaching that six-figure benchmark for financial security may seem impossible, especially when pushes to raise the federal minimum wage fail to materialize. Today, 34 states and territories have minimum wages around the federal hourly minimum of $7.25 per hour. That rate has not increased since 2009. Five states — Alabama, Louisiana, Mississippi, South Carolina, and Tennessee — use the federal minimum wage, and three states have a lower minimum wage than the federal minimum. While the push for a $15 minimum wage was championed primarily by progressive voices like Sen. Bernie Sanders, the idea has gained broader momentum in Congress, even among some Republicans like Sen. Josh Hawley. Sanders attempted to add a provision raising the federal minimum wage to $15 in 2021 as part of Joe Biden's COVID-19 stimulus bill, but the effort was killed in the Senate. That same year, the National Low Income Housing Coalition's annual 'Out of Reach' report found that minimum wage workers in 93 percent of U.S. counties would not be able to afford a modest one-bedroom apartment. But even moderate raises aren't going to go far enough to reduce the financial pressures facing modern American adults. The current typical national salary for a full-time, year-round worker was $81,515 in 2023, according to the latest figures from the Bureau of Labor Statistics. Typically, the more direct path toward making more money is switching jobs, but even that avenue has become more difficult for many workers. Many companies have slowed or stopped hiring, making it that much harder for Americans to increase their salaries. The financial realities of the modern world are a far cry from the idyllic American Dream — that an American who works a full-time job can afford a home, transportation, raise their children, and have enough left over to enjoy their lives — and that reality doesn't seem to be changing anytime soon. 'Though many Americans hold onto the idea of returning to a 1950s-era 'Golden' America age, the days when a single, non-college educated breadwinner could sustain an entire family seem like they may be confined forever to the past,' Bankrate economy reporter Sarah Foster said.
